After Lixi: What Zealand Is Doing Next

 
• By Sten Stovall

Zealand CEO Britt Meelby Jensen says the Danish developer of novel peptides for treating gastrointestinal and metabolic diseases is successfully raising its global profile via a growing proprietary pipeline.

Magnify
Zealand's CEO Seeks To Focus Attention On Its Proprietary Pipeline • Source: Shutterstock

More from Strategy

More from Business